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ABSTRACT
The role of hepatobiliary transporters in drug-induced liver injury remains poorly understood. Various in vivo and in vitro
biological approaches are currently used for studying hepatic transporters; however, appropriate localization and
functional activity of these transporters are essential for normal biliary flow and drug transport. Human hepatocytes (HHs)
are considered as the most suitable in vitro cell model but erratic availability and inter-donor functional variations limit
their use. In this work, we aimed to compare localization of influx and efflux transporters and their functional activity in
differentiated human HepaRG hepatocytes with fresh HHs in conventional (CCHH) and sandwich (SCHH) cultures. All tested
influx and efflux transporters were correctly localized to canalicular [bile salt export pump (BSEP), multidrug resistance-
associated protein 2 (MRP2), multidrug resistance protein 1 (MDR1), and MDR3] or basolateral [Naþ-taurocholate co-
transporting polypeptide (NTCP) and MRP3] membrane domains and were functional in all models. Contrary to other
transporters, NTCP and BSEP were less abundant and active in HepaRG cells, cellular uptake of taurocholate was 2.2- and
1.4-fold and bile excretion index 2.8- and 2.6-fold lower, than in SCHHs and CCHHs, respectively. However, when
taurocholate canalicular efflux was evaluated in standard and divalent cation-free conditions in buffers or cell lysates, the
difference between the three models did not exceed 9.3%. Interestingly, cell imaging showed higher bile canaliculi
contraction/relaxation activity in HepaRG hepatocytes and larger bile canaliculi networks in SCHHs. Altogether, our results
bring new insights in mechanisms involved in bile acids accumulation and excretion in HHs and suggest that HepaRG cells
represent a suitable model for studying hepatobiliary transporters and drug-induced cholestasis.
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ABBREVIATIONS
BEI bile excretion index
BSEP bile salt export pump
CDFDA 5(6)-carboxy-20,70-dichlorofluorescein diacetate
CCHH conventional cultured human hepatocyte
HH human hepatocyte
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JC-1 5,50,6,60-Tetrachloro-1,10,3,30-tetraethylbenzimida-
zolo carbocyanine iodide
MDR multidrug resistance protein
MK571 5 -(3-(2-(7-Chloroquinolin-2-yl)ethenyl)phenyl)-8-
dimethylcarbamyl-4,6-dithiaoctanoic acid sodium
salt hydrate
MRP multidrug resistance-associated protein
NTCP Naþ-taurocholate co-transporting polypeptide
OATP organic anion transporting polypeptide
PBS phosphate buffered saline
SCHH sandwich-cultured human hepatocyte
TCA taurocholic acid.
Hepatocytes are highly polarized cells exhibiting specialized
apical (canalicular) and sinusoidal (basolateral) domains. They
import and export a variety of exogenous and endogenous sub-
strates largely via membrane transporters that are divided into
two major groups: influx transporters mediating cellular uptake
of appropriate substrates and efflux transporters responsible for
their excretion into bile canaliculi or blood (Giacomini et al.,
2010). Bile acids and drugs are their main substrates; 95% of bile
acids secreted into bile are reabsorbed in the ileum, diffused
across the enterocyte to the basolateral membrane, exported
into portal blood circulation, extracted at the hepatocyte
sinusoidal membrane, and re-secreted into bile contributing
therefore to bile formation through the so-called entero-hepatic
circulation (Hofmann, 1999).
Hepatic uptake of biliary constituents at the sinusoidal do-
main of hepatocytes is mediated by both sodium-dependent
and independent mechanisms (Nathanson and Boyer, 1991).
Although sodium-independent uptake of bile salts is carried by
members of the organic anion transporting polypeptide family
(OATPs/SLCOs), sodium-dependent uptake is mediated by the
Naþ-taurocholate co-transporting polypeptide (NTCP/SLC10A1)
that represents the most relevant uptake system. It accounts for
the uptake of the major part of conjugated bile acids and less
than half of unconjugated bile acids (Kullak-Ublick et al., 2000;
Meier and Stieger, 2002). Bile salts are then carried across the
hepatocyte and secreted into bile via canalicular transporters.
Canalicular transport of bile constituents is mainly mediated
by ABC superfamily transporters: bile salt export pump (BSEP/
ABCB11), multidrug resistance-associated protein 2 (MRP2/
ABCC2), P-glycoprotein [multidrug resistance protein 1 (MDR1)/
ABCB1], phospholipid flippase (MDR3/ABCB4), and breast cancer
resistance protein (BCRP/ABCG2). Although BSEP exports
monovalent bile salts and is responsible for bile salt-depen-
dent flow, MRP2 excretes divalent bile salts, glutathione and
its conjugates, generating therefore the major part of bile salt
independent bile flow (Kullak-Ublick et al., 2000). MDR1 has
been shown to transport amphipathic organic cations,
whereas MDR3 translocates phosphatidylcholine from the in-
ner to the outer leaflet of the canalicular membrane
(Lefebvre et al., 2009). An alternative efflux system belong-
ing to the MDR subfamily, represented by MRP3 and MRP4,
is localized to the basolateral membrane domain and pro-
vides an alternative excretory route for bile constituents
when their canalicular excretion is impaired (Trauner and
Boyer, 2003).
Impairment of bile flow is called cholestasis and may be
caused by a functional impairment of canalicular secretory pro-
cesses, which in turn results in an intracellular accumulation of
cholephilic compounds, such as bile salts (Trauner et al., 1998).
Intrahepatic cholestasis of pregnancy and drug-induced
cholestasis are acquired forms of cholestasis (Pauli-Magnus
et al., 2010). Drug-induced cholestasis may lead to drug-induced
liver injury in humans. In many cases of acquired forms of cho-
lestasis, activity and cellular distribution of hepatobiliary trans-
porters are altered. Other mechanisms, such as altered cell
polarity as a consequence of mistargeting of intracellular trans-
port vesicles, cytoskeletal modification, disrupted cell–cell junc-
tions, or deregulated signaling pathways may be involved in
acquired cholestasis (Trauner and Boyer, 2003). Finally, oxidative
stress as a primary causative agent and/or as an aggravating fac-
tor has been linked to cholestatic liver injury (Antherieu et al.,
2013; Copple et al., 2010; Perez et al., 2006; Roma and Sanchez
Pozzi, 2008).
Although major progress has been made in the knowledge of
transporters, their regulation and interactions with drugs
and substrates, their role in drug-induced liver injury, in partic-
ular drug-induced cholestasis, requires further investigations
(Corsini and Bortolini, 2013; Liu et al., 2014). Various in vivo and
in vitro biological approaches are currently used for studying he-
patic transporters. Sandwich-cultured primary hepatocytes are
considered as the most appropriate cell model to mimic the
hepatobiliary secretory process (De Bruyn et al., 2013); because
major species differences have been reported in this process,
the use of sandwich-cultured primary human hepatocytes
(SCHHs) is desirable (Guguen-Guillouzo and Guillouzo, 2010;
Swift et al., 2010).
Recent studies have shown that cholestasis can be induced
by drugs in human HepaRG cells, a human liver cell line ex-
pressing features of mature hepatocytes and exhibiting typical
bile canaliculi. These findings suggest that HepaRG cells may be
useful to mechanistically better understand drug-induced alter-
ations of bile acids influx and efflux (Antherieu et al., 2013;
Sharanek et al., 2014). Whether the transport process in this cell
model compares well with that in primary HHs in conventional
or sandwich configuration remains currently unanswered. In
this work, we showed that cellular localization and functional
activity of the main hepatobiliary transporters were comparable
in HepaRG cells and primary HHs.
MATERIALS ANDMETHODS
Reagents. Phalloidin fluoprobe was purchased from Interchim
(Montluc¸on, France), [3H]-taurocholic acid ([3H]-TCA) was pur-
chased from Perkin Elmer (Boston, Massachusetts), verapamil,
5 -(3-(2-(7-Chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcar-
bamyl-4,6-dithiaoctanoic acid sodium salt hydrate (MK571) and
5(6)-carboxy-20,70-dichlorofluorescein diacetate (CDFDA) were
purchased from Sigma (St Quentin Fallavier, France).
5,50,6,60-Tetrachloro-1,10,3,30-tetraethylbenzimidazolo carbocya-
nine iodide (JC-1 dye) was obtained from Invitrogen-Molecular
probes (Saint Aubin, France). Hoechst dye was obtained
from Promega (Madison, Wisconsin). All primary antibodies,
except BSEP and NTCP antibodies (from Dr B. Stieger laboratory),
were obtained from Abcam (Cambridge, United Kingdom).
Secondary antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz). All other reagents were obtained
from Sigma.
Cell cultures. HepaRG cells were seeded at a density of
2.6 104 cells/cm2 in Williams’ E medium supplemented with
10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml strepto-
mycin, 5 mg/ml insulin, 2 mM glutamine, and 50 mM hydrocorti-
sone hemisuccinate. After 2 weeks, HepaRG cells were shifted to
the same medium supplemented with 1.7% dimethyl sulfoxide
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for 2 additional weeks to obtain confluent differentiated
cultures. At that time, cultures contained equal proportions
of hepatocyte-like and progenitors/primitive biliary-like cells
(Cerec et al., 2007).
HHs were obtained from Biopredic International (St Gregoire,
France). They were isolated by collagenase perfusion of histo-
logically normal liver fragments from 8 adult donors undergoing
resection for primary and secondary tumors (Guguen-Guillouzo
et al., 1982). Primary cultures were obtained by hepatocyte seed-
ing at a density of 1.5 105 cells/cm2 onto collagen-precoated
plates in Williams’ E medium supplemented with 10% fetal
bovine serum, 100 units/ml penicillin, 100 mg/ml streptomycin,
1 mg/ml insulin, 2 mM glutamine, and 1 mg/ml bovine serum
albumin. The medium was discarded 12 h after cell seeding, and
cultures were thereafter either maintained in the same medium
as for HepaRG cells and designated as conventional cultured
human hepatocytes (CCHHs), or after 24–48 h washed with cold
medium and overlaid with matrigel at a concentration of
0.25 mg/ml in ice-cold Williams’ E medium for the preparation
of SCHHs. The medium of both CCHHs and SCHHs was renewed
every day. CCHHs and SCHHs were prepared from the same
donors and analyzed in parallel. SCHHs were used after at least
3-day matrigel overlay.
Immunolabeling. Cells were washed with warm phosphate buf-
fered saline (PBS), fixed with either methanol for 15 min at 20C
or with 4% paraformaldehyde for 20 min at 4C, and then washed
three times with cold PBS. After paraformaldehyde fixation, cells
were permeabilized for 20 min with 0.3% Triton in PBS followed by
1-h incubation in PBS containing 1% bovine serum albumin and
5% normal donkey serum. Cells were then incubated overnight
with primary antibodies directed against NTCP (Kullak-Ublick
et al., 1997) and BSEP (Noe et al., 2002) diluted at 1/200 and 1/50,
respectively, MRP2 (M2III-6, Abcam) diluted at 1/100, MRP3 (M3II-9,
Abcam), MDR1 (JSB-1, Abcam), or MDR3 (P3II-26, Abcam) diluted
at 1/50 in PBS containing 1% bovine serum albumin and 5% nor-
mal donkey serum. After washing with cold PBS cells were incu-
bated for 2 h with goat or rabbit Alexa fluor 488 labeled secondary
antibodies in the same buffer as described earlier. Finally, cells
were again washed with cold PBS and incubated with Hoechst
and phalloidin in PBS for 20 min for F-actin and nuclei labeling,
respectively. Immunofluorescence images were detected by
Cellomics ArrayScan VTI HCS Reader (ThermoScientific, New
Hampshire).
F-actin distribution. After fixation of cells as described earlier,
cytoskeletal F-actin was localized using phalloidin fluoprobe
SR101 (200 U/ml) diluted at 1/100 for 20 min as described previ-
ously (Pernelle et al., 2011). Nuclei were labeled with 5 ng/ml
Hoechst dye in parallel to F-actin labeling.
Functional activity of MDRs. The JC-1 metachromatic dye is
translocated across the canalicular membrane via MDRs,
particularly MDR1 (Legrand et al., 2001). It does not
accumulate in differentiated HepaRG hepatocytes without pre-
incubation with verapamil, an inhibitor of MDRs (Pernelle et al.,
2011). Briefly, cells were incubated in the presence or absence
of 50 lM verapamil (an inhibitor of MDRs) for 30 min, and
then verapamil was washed out with warm PBS before 30 min
incubation with 7 lM JC-1 at 37C. Imaging was done
by Cellomics ArrayScan VTI HCS Reader. Above a critical intra-
cellular concentration, JC-1 forms dimers that display a
specific red emission, whereas the monomers display a green
emission.
NTCP activity. Activity of the NTCP transporter was measured
through determination of radiolabeled TCA in cellular layers
(cells plus bile canaliculi) (Antherieu et al., 2013). Briefly, HepaRG
cells and 4–5 days CCHHs and SCHHs were washed twice with
PBS and then incubated with [3H]-TCA for 30 min in a buffer
containing or not sodium ions. Cells were then washed twice
with PBS and lysed with 0.1 N NaOH. Accumulation of the radio-
labeled substrate in cellular layers was determined through
scintillation counting.
Efflux of TCA. HepaRG cells and 4–5 days CCHHs and SCHHs were
exposed to [3H]-TCA for 30 min, and then washed with PBS.
Efflux of radiolabeled TCA was assessed for 30 min in either
standard or Ca2þ- and Mg2þ-free buffer. Cells were then scraped
in 0.1 N NaOH and accumulation of radiolabeled substrate into
cellsþbile canaliculi (in the presence of Ca2þ- and Mg2þ-ions)
and into cells only (in the absence of Ca2þ- and Mg2þ-ions) was
measured through scintillation counting to evaluate TCA efflux.
Absence of divalent cations promotes disruption of tight junc-
tions and induces bile canaliculi opening (Liu et al., 1999). This
technology, called B-CLEAR technology, is patented and exclu-
sively licensed to the Qualist Transporter Solutions Company,
Durham, North Carolina.
To determine the contribution of passive diffusion to TCA
efflux, cells were incubated in parallel in either standard or
Ca2þ- and Mg2þ-free buffer for 30 min at 37C or in standard buf-
fer at 4C after TCA uptake. Radiolabeled TCA was measured in
all buffers and cells to calculate the relative contribution of dif-
fusion and basolateral and canalicular efflux of TCA (Jemnitz
et al., 2010; Liu et al., 1999; Marion et al., 2012). Three different
methods were used for calculation of efflux activity.
First, biliary excretion index (BEI) (method I), which
represents the percentage of [3H]-TCA that is excreted into
bile canaliculi, was calculated using the following equation:
BEI¼ [(AccumulationCellsþ Bile canaliculi  AccumulationCells)/
AccumulationCells þ Bile canaliculi] 100% (Liu et al., 1999).
The second method (method II) was based on the accumula-
tion of TCA, after a 30-min efflux period, in cell lysates in the
presence and absence of divalent cations (Liu et al., 1999). Using
TCA accumulation in cell lysates, diffusion, and basolateral and
canalicular efflux were calculated using the following
equations:
T0¼Total TCA uptake into the cell layer after 30 min incubation
in standard buffer.
Total efflux¼T0AccumulationCells at 37C.
Diffusion¼ (T0AccumulationCellsþ Bile canaliculi at 4C) 100%/
Total efflux.
The value “T0AccumulationCellsþ Bile canaliculi at 4C” represents
the radiolabeled TCA that diffused out of cell layer.
Basolateral efflux¼ [(T0AccumulationCellsþ Bile canaliculi at
37C) 100%/Total efflux]Diffusion.
The value “T0AccumulationCellsþ Bile canaliculi at 37C” represents
the radiolabeled TCA that is excreted in the medium either by
basolateral transporters or by passive permeability.
Canalicular efflux¼ 100% (Basolateral Effluxþdiffusion).
The third method (method III) was based on radiolabeled TCA
measured after a 30-min efflux period in standard and Ca2þ-
and Mg2þ-free buffer (Jemnitz et al., 2010). Radioactivity in
standard buffer at 37C represented basolateral efflux and pas-
sive diffusion of TCA, whereas that in Ca2þ- and Mg2þ-free
buffer corresponded to canalicular efflux in addition to baso-
lateral efflux and passive diffusion.
Total efflux¼Radioactivity in Ca2þ and Mg2þ-free buffer at 37C.
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Diffusion¼Radioactivity in standard buffer at 4C 100%/Total
efflux.
Basolateral efflux¼ (Radioactivity in standard buffer at
37CRadioactivity in standard buffer at 4C) 100%/Total
efflux.
Canalicular efflux¼ (Radioactivity in Ca2þ- and Mg2þ-free buffer
at 37CRadioactivity in standard buffer at 37C) 100%/Total
efflux.
CDF excretion. Cells were washed with warm PBS, pre-incubated
for 20 min in the presence or absence of 30 lM MK571, an inhibi-
tor of MRP2, before addition of 2 lM CDFDA for 30 min at 37C in
either standard or Ca2þ- and Mg2þ-free buffer. Upon hydrolysis
of CDFDA by intracellular esterases, CDF is secreted into the bile
canaliculi by membrane transporters, particularly MRP2
(Zamek-Gliszczynski et al., 2003). Cells were then washed with
PBS, and imaging was done using inverted microscope Zeiss
Axiovert 200 M and AxioCam MRm.
Time-lapse imaging. Phase-contrast images of HepaRG cells,
CCHHs, and SCHHs were captured each minute, using time-lapse
phase-contrast videomicroscopy. The inverted microscope Zeiss
Axiovert 200 M was equipped with a thermostatic chamber (37C
and 5% CO2) to maintain the cells under normal culture condi-
tions. Images were captured by AxioCam MRm camera with a
20 objective and the mosaic tool of the microscope, which
enabled the automated acquisition of multi-image mosaics at the
defined positions.
Statistical analysis. One-way ANOVA with Bonferroni’s multiple
comparison test (GraphPad Prism 6.00) was performed to com-
pare data between the three cell models. Each value corre-
sponded to the mean6 standard deviation (SD) of at least three
independent experiments. Data were considered significantly
different when P< 0.05.
RESULTS
HepaRG Cell and HH Polarity
Under phase-contrast microscopy, HepaRG hepatocytes and
HHs either in conventional culture or in a sandwich configura-
tion formed clusters with well-defined intercellular structures
resembling characteristic bile canaliculi (Fig. 1A).
FIG. 1. Bile canaliculi networks in HepaRG cell and HH cultures. A, Bile canaliculi structures (arrows) in differentiated HepaRG cells and 4–5 days HHs cultured in sand-
wich (SCHH) and conventional (CCHH) configuration were observed under phase-contrast microscopy (20 magnification). B, Pericanalicular F-actin microfilament net-
work after labeling with phalloidin-fluoprobe in HepaRG cells (nuclei stained in using Hoechst dye) and 4–5 days HHs cultured in sandwich and conventional
configuration. Imaging was done using Cellomics ArrayScan VTI HCS Reader (ThermoScientific). C, Electron microscopic micrograph of tight junctions surrounding bile
canaliculus structures in HepaRG cells (arrows), original magnification3000 (bar¼2 lm). H, hepatocyte; BC, bile canaliculus.
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Polarity of the different hepatocyte models was analyzed
by phalloidin fluoprobe labeling of cytoskeletal F-actin.
Labeling was particularly abundant in the pericanalicular areas
which defined multiple shapes of bile canaliculi in primary hep-
atocytes. In SCHHs, these structures showed a time-dependent
progression in the formation of a branched bile canalicular
network and were more elongated than in corresponding
CCHHs, especially after 4–5 days (Fig. 1B). HepaRG cells also
showed abundant pericanalicular cytoskeletal F-actin and
sparse network of microfilaments beneath the plasma mem-
brane defining the cell shape. At the electron microscopic level,
bile canaliculi appeared to be surrounded by large tight junc-
tional complexes in HepaRG hepatocytes (Fig. 1C). Accordingly,
the mean surface of bile canaliculi networks was estimated
by measuring CDF-labeled lumen surfaces using vHCS.scan
(V6.2.0) cellomics software and found to be 1.7 - and 1.3-fold
higher in SCHHs than in HepaRG cells and CCHHs, respectively
(Fig. 2).
Moreover, dynamics of bile canaliculi was assessed by
time-lapse imaging, which allowed to analyze living cells
directly over time. Some bile canaliculi showed contractions
and relaxations in HepaRG cells, indicating that they were
active and periodically clearing accumulated products. No
synchronism was observed, even within a hepatocyte cluster
(Fig. 3A). Such contractions and relaxations were slower in
CCHHs (Fig. 3B) and difficult to visualize in SCHHs, likely due to
the elongated shape of bile canaliculi and the upper matrigel
layer.
Cellular Localization of Bile Acid Transporters
Localization of several main hepatobiliary transporters was
assessed by immunofluorescence staining in HepaRG cells as well
as in 4–5 days SCHHs and CCHHs. Importantly, in HepaRG cell cul-
tures transporter immunolabeling was restricted to hepatocyte-
like cells; no transporter was visualized in primitive biliary cells.
Influx Transporter
NTCP was localized to the sinusoidal membrane domain in
CCHHs and SCHHs. However, immunolabeling was weaker in
the former. Similarly to SCHHs, HepaRG cells showed a faint
sinusoidal membrane staining and in addition a diffuse intracy-
toplasmic labeling for NTCP (Fig. 4).
Efflux Transporters
Basolateral domain. MRP3 was exclusively localized to the sinus-
oidal plasma membrane domain in all the liver cell models with
a more intense labeling in HepaRG cells (Fig. 4).
Canalicular domain. Four canalicular transporters, BSEP, MRP2,
MDR1, and MDR3, were immunolocalized in HHs and HepaRG
cells (Fig. 4). In HHs, BSEP co-localized with cytoskeletal F-actin
and was detected on canalicular membranes. It displayed a faint
canalicular immunolabeling in HepaRG cells with in addition, a
slight heterogeneous intracytoplasmic labeling (Supplementary
Fig. 1). The other canalicular transporters, MRP2, MDR1, and MDR3,
were well visualized, exclusively on canalicular membranes in the
three liver cell models, with a more intense labeling of MRP2
and MDR1 in HepaRG cells (Fig. 4).
Transporter Activities
Sodium-dependent activity of NTCP. To assess whether the influx
of TCA was sodium-dependent, HepaRG cells and HHs were
incubated for 30 min with [3H]-TCA in the presence or absence
of sodium ions. Accumulation of radiolabeled TCA in cellular
layers was then measured. Uptake of TCA by HepaRG cells was
more than 42-fold greater in the presence of sodium demon-
strating that NTCP displayed a sodium-dependent activity as in
the in vivo situation (Fig. 5A). It was 33 and 15 times greater in
presence of sodium in SCHHs and CCHHs, respectively. When
measured per hepatocyte NTCP activity was around 2.2 - and
1.4-fold higher in SCHHs and CCHHs than in HepaRG cells,
respectively (Fig. 5B).
Activity of efflux transporters. Efflux of CDF and [3H]-TCA, sub-
strates of MRP2 and BSEP, respectively, was assessed in stand-
ard and Ca2þ- and Mg2þ-free buffer. After 30 min incubation
with CDFDA in standard buffer, fluorescent CDF was visualized
in bile canaliculi of both HepaRG cells and 4–5 days SCHHs and
CCHHs (Figs. 2 and 6). In contrast, absence of sharp canalicular
labeling was noticed in Ca2þ- and Mg2þ-free buffer, particularly
in SCHHs. Although many bile canaliculi were still labeled in
HepaRG cells despite the depletion in divalent cations, the total
number of fluorescent canaliculi was clearly reduced. No well-
defined canalicular labeling was observed when incubation was
performed in the presence of MK571, an inhibitor of MRP2 and
the two other major ABC transporters MDR1 and BCRP (Matsson
et al., 2009).
Canalicular excretion of taurocholate was first quantified
using BEI values (method I). BEI of TCA represented 26.6, 70.9,
and 74.2% in HepaRG cells, CCHHs, and SCHHs, respectively
(Table 1). To determine the relative contribution of diffusion,
and basolateral and canalicular efflux of TCA, two other modes
of calculation of TCA efflux were also used based on measure-
ment of radiolabeled TCA in cell lysates and buffers (after incu-
bation in buffer containing or not Ca2þ and Mg2þ) at 4 and 37C.
Incubation of cells at 4C blocked all active transport systems,
thereby allowing determination of the percentage of TCA
released by diffusion (passive permeability). When calculation
was based on the accumulation of radiolabeled TCA in cell
lysates (method II) after incubation in a buffer containing or not
divalent cations, canalicular efflux, basolateral efflux and diffu-
sion were found to contribute nearly equally to TCA release in
HepaRG cells and CCHHs, whereas in SCHHs canalicular and
basolateral efflux were around 6–8% higher and diffusion was
12–16% lower compared with the two other cell models (Table 1).
When radiolabeled TCA was quantified in incubation buffers
(method III) containing or not Ca2þ and Mg2þ a higher contribu-
tion of basolateral efflux was observed; it became the major
route of TCA excretion in HepaRG cells, SCHHs and CCHHs, ie
57.6, 43, and 35%, respectively, compared with the canalicular
efflux that represented 28.5, 37.9, and 26.3%, respectively. The
contribution of passive permeability to total TCA excretion was
clearly lower in HepaRG cells and SCHHs (13.9 and 19.1%,
respectively), whereas it remained the major route in CCHHs
(38.8%). Noteworthy, when basolateral efflux and diffusion val-
ues obtained from measurements in cell lysates (method II)
were summed, their percentages represented 68.7, 61.5, and
69.2% of total TCA efflux in HepaRG, SCHHs, and CCHHs, respec-
tively; those summed from measurements in buffers (method
III) gave comparable percentages representing 76.1, 62.1, and
73.7%, respectively.
MDRs activity. Incubating HepaRG cells with JC-1 dye resulted
in red and green cell areas in the same microscopic field (Fig. 7).
The red cell areas corresponded to primitive biliary cells,
which did not express MDRs, whereas green ones represented the
hepatocytes, which displayed MDRs proteins across their
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FIG. 2. Bile canaliculi networks in HepaRG cells and primary HHs. Bile canaliculi were labeled using CDFDA, a MRP2 substrate in A, HepaRG cells, SCHHs, and CCHHs. B,
The mean surface areas of bile canaliculi networks in HepaRG cells and 4–5 days HHs cultured in sandwich and conventional configuration were estimated by quantify-
ing CDFDA-labeled lumen surfaces using vHCS.scan (V6.2.0) cellomics software (ThermoScientific). Data represent the means6SD of at least three independent experi-
ments. Data with P<0.05 is considered significant (*).
FIG. 3. Bile canaliculi dynamics in HepaRG cells and HHs. Time-lapse imaging of HepaRG cells and 4–5 days HHs cultured in conventional configuration (CCHH). Time-
dependent contraction/relaxation activity of bile canaliculi (arrows). Imaging was done using inverted microscope Zeiss Axiovert 200 M and AxioCam MRm.
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canalicular plasma membrane. By transporting JC-1 out of the
cells, MDRs did not allow the dye to reach critical concentration
to form dimers. Only pre-incubation with verapamil, an inhibitor
of MDRs, before JC-1 exposure resulted in dimer fluorescence in
both cell types.
DISCUSSION
Although previous studies have demonstrated that the majority
of hepatobiliary transporters (organic cation transporter 1,
OATP1B1, OATP2B1, NTCP, MRP2, MRP3, BSEP, and MDR1) are
expressed in differentiated HepaRG cells, their distribution and
FIG. 4. Distribution of main bile acid transporters in HepaRG cells and HHs. Differentiated HepaRG cells and 4–5 days HHs in sandwich (SCHH) and conventional (CCHH)
cultures were fixed and incubated with primary antibodies against each of the following hepatobiliary transporters: NTCP, MRP3, BSEP, MRP2, MDR1, and MDR3. Nuclei
were labeled using Hoechst. Immunofluorescence images were obtained with a Cellomics ArrayScan VTI HCS Reader (ThermoScientific).
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activity are still poorly documented (Antherieu et al., 2010;
Kotani et al., 2012; Le Vee et al., 2013; Szabo et al., 2013). In this
study, we compared the localization and functional activity of
the main membrane transporters in HepaRG cells and HHs in
conventional and sandwich configuration. The major hepato-
biliary transporters including BSEP and NTCP, were visualized
by immunolabeling and found to be correctly distributed on
canalicular and basolateral membrane domains, respectively,
and to be functional in the three liver cell models. Noteworthy,
primitive biliary HepaRG cells did not express detectable mRNA
and protein of any tested transporter and accordingly, did not
accumulate TCA (Sharanek et al., 2014).
A basolateral NTCP localization together with a sodium-
dependent activity (Kotani et al., 2012) has been evidenced in
both HepaRG cells and primary HHs. Compared to CCHHs and
SCHHs, HepaRG cells showed weaker labeling and activity of
NTCP which is in agreement with lower corresponding mRNA
levels as previously measured in these cells compared with
freshly isolated or 1-day HHs (Antherieu et al., 2012; Le Vee et al.,
2013). In contrast, other authors found that NTCP transcripts
and protein levels were more than 2-fold higher in HepaRG cells
than in cryopreserved primary HHs (Kotani et al., 2012). This dis-
crepancy likely resulted from the use of cryopreserved HHs in
the latter study. Indeed, a marked reduction of protein content
and activity of NTCP and other influx transporters has recently
been reported in HHs associated with the freeze/thaw process
(Lundquist et al., 2014).
Immunolabeling of BSEP showed canalicular distribution of
this transporter in HHs whatever their mode of culture, in
agreement with its apical localization in human liver biopsies
FIG. 6. Functional activity of MRP2 in HepaRG cells and HHs. MRP2 activity was estimated using CDFDA in HepaRG cells and 4–5 days SCHHs and CCHHs. Efflux of fluo-
rescent CDF, a substrate of MRP2, characterized by accumulation of fluorescence into bile canaliculi, was evaluated in standard and Ca2þ- and Mg2þ-free buffer in the
presence and absence of MK571, an inhibitor of MRP2. Imaging was done using inverted microscope Zeiss Axiovert 200 M and AxioCam MRm.
FIG. 5. Sodium-dependent activity of NTCP in HepaRG cells and HHs. HepaRG cells and 4–5 days HHs in sandwich (SCHH) and conventional (CCHH) cultures were incu-
bated with [3H]-TCA for 30 min in the presence and absence of sodium ions. A, NTCP activity was evaluated through measurement of the radiolabeled substrate TCA
accumulated in cellular layers (cells plus bile canaliculi). Uptake of [3H]-TCA in each cell model was expressed relative to the levels found in cells incubated with Naþ-
free buffer, arbitrarily set at a value of 1. B, NTCP activity was evaluated in the presence of Naþ as the ratio of total radioactivity measured in cell lysates to total number
of hepatocytes in each cell model. Calculations were based on 800 000 hepatocytes in the two primary hepatocyte models and 280 000 HepaRG hepatocytes per well.
Results are expressed relative to NTCP activity found in HepaRG hepatocytes, arbitrarily set at a value of 1. Data represent the means6SD of at least three independent
experiments. Data with P<0.05 are considered significant (*).
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and rat hepatocyte couplets (Boaglio et al., 2010; Zollner et al.,
2001). Although much weaker than in HHs, in accordance with
lower corresponding mRNA levels (Antherieu et al., 2012; Le Vee
et al., 2013), BSEP was also detected on canalicular membranes
of HepaRG cells. Moreover, noticeably, intracellular labeling was
in addition observed in HepaRG cells as previously reported for
rat hepatocytes in situ and for the WIF-B cell line (Gerloff et al.,
1998; Gradilone et al., 2005; Soroka et al., 1999). It has been
emphasized that intracellular BSEP is capable of trafficking
within minutes to the canalicular membrane when the demand
for BSEP increased (Kipp and Arias, 2002). To our best knowl-
edge, this study is the first immunolocalization of BSEP in
HepaRG cells and primary HH cultures.
Localization of MRP2, MDR1, and MDR3 was restricted to
canalicular membranes, whereas MRP3 was exclusively local-
ized to the basolateral membrane domain in both HepaRG cells
and HHs. Although no quantification was performed, immuno-
labeling of MRP2, MDR1, and MRP3 appeared to be more intense
in HepaRG cells than in HHs, in agreement with previous stud-
ies showing overexpression of these genes at the transcriptional
level in the former (Antherieu et al., 2012; Le Vee et al., 2013).
This study provided clear evidence that the canalicular efflux
transporters BSEP, MRP2, and MDRs were functional and that
cholephilic substances could accumulate in bile canaliculi.
BSEP and MRP2 substrates were demonstrated inside bile canal-
iculi of the three hepatocyte models and functional activity of
MDR1 was evidenced in HepaRG hepatocytes using the JC-1
metachromatic dye of which continuous excretion by MDR1
was prevented following pre-incubation with the MDR1 inhibi-
tor verapamil.
BEI values (method I) were higher in SCHHs and CCHHs than
in HepaRG cells, ie 74.2, 70.9, and 26.6%, respectively. Using
other modes of calculation based on radioactivity measured in
cell lysates (method II) and incubation buffers (method III)
(Jemnitz et al., 2010; Liu et al., 1999), contribution of canalicular
efflux to total excretion of TCA was found to be comparable to
the BEI in HepaRG cells, representing 31.3 and 28.5%, respec-
tively. The BEI found in this study is close to that previously
reported by others (Le Vee et al., 2013). Similarly, the highest
values found in SCHHs were comparable to those previously
obtained by Marion et al. (2007). However, in another study,
Marion et al. (2012) found much lower BEI values in SCHHs. Such
large differences (41.7% vs 73.2%) could reflect the well-known
interindividual variations of functional activities in HHs. It has
been previously reported that efflux of taurocholate was around
40–50% greater in SCHHs than in CCHHs (Kostrubsky et al.,
2003). The comparable BEI values found in the two primary hep-
atocyte models in this study could be explained by the use of
fresh cells and our experimental conditions, including the type
of culture medium and the choice of 4–5 days of culture before
analysis of bile acid excretion. At that time, primary HHs
express high levels of drug metabolizing enzymes activities and
other functions (Abdel-Razzak et al., 1993).
The lower BEI in HepaRG cells compared with SCHHs and
CCHHs could have several nonexclusive explanations. First, an
attenuated NTCP and BSEP activity in comparison to HHs regard-
less their mode of culture. In accordance, when the amount of
accumulated TCA in cell layers was calculated per hepatocyte, it
was 2.2 - and 1.4-fold higher in sandwich and standard cultured
HHs than in HepaRG hepatocytes, respectively. Such attenuated
FIG. 7. MDRs activity in HepaRG cells. HepaRG cells were incubated for 30 min in the presence or absence of 50lM verapamil, an inhibitor of MDRs, before 30 min incu-
bation with 7 lM JC-1. A significant intracellular accumulation resulting in the formation of JC-1 dimers characterized by heterogeneous intracytoplasmic staining was
observed in HepaRG hepatocytes (þ verapamil). Imaging was done using Cellomics ArrayScan VTI HCS Reader (ThermoScientific).
TABLE 1. Different Modes of Calculation of TCA Efflux in the Three
Human Liver Cell Models
HepaRG SCHH CCHH
BEI (%) 26.5867.26 74.156 8.67* 70.94613.38*
Cell lysates
Canalicular efflux (%) 31.2669.75 38.536 15.75 30.7769.10
Basolateral efflux (%) 32.7367.34 38.056 18.88 30.0661.11
Diffusion (%) 36.0266.98 23.426 14.57 39.1768.37
Basolateralþdiffusion (%) 68.7569.75 61.476 15.75 69.2369.10
Buffers
Canalicular efflux (%) 28.5264.77 37.866 24.63 26.2769.22
Basolateral efflux (%) 57.5866.36 43.006 24.16 34.9565.69
Diffusion (%) 13.8963.47 19.146 11.76 38.77614.91
Basolateralþdiffusion (%) 71.4766.27 62.146 24.63 73.7269.22
HepaRG cells and 4–5 days SCHHs and CCHHs were exposed to [3H]-TCA for 30 min
to induce uptake of TCA. After 30min incubation in standard and Ca2þ- and Mg2þ-
free buffer at 4 and 37C, TCA efflux was determined by measuring radioactivity in
cell lysates and buffers. The values measured in HepaRG cells (HepaRG), and
SCHHs and CCHHs are expressed as BEI or as percentages of total efflux6SD
(n 3) and were calculated as described in ‘Materials and methods’ section.
Conventional and sandwich cultures of fresh HHs were prepared from the same
donors and analyzed in parallel. Data with P<0.05 is considered significant (*).
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NTCP and BSEP activity is supported by low corresponding mRNA
levels (Antherieu et al., 2012; Le Vee et al., 2013) and results in
reduced TCA uptake and canalicular excretion. These low NTCP
and BSEP activities could explain the 2.8-fold lower BEI values
compared with SCHHs. Second, the overexpression of MRP3
mRNA in HepaRG cells (Antherieu et al., 2012; Le Vee et al., 2013)
could explain the higher contribution of this route to total excre-
tion of TCA. Third, the smaller size of the bile canaliculi network
and the higher contraction/relaxation activity promoting a con-
tinuous discharge of their content. Forth, an incomplete opening
of HepaRG bile canaliculi in cation-free buffer, because of the
large size of tight junctions as observed under electron micro-
scopy. This hypothesis is based on the sharp CDF-fluorescent
labeling in many bile canaliculi in the absence of divalent cations
in HepaRG cells, whereas such labeling was nearly completely
absent in SCHHs. Noticeably, a 10–15% increase in canalicular
TCA and CDF efflux was measured by using higher concentra-
tions of the divalent cation chelator EGTA (data not shown). As a
consequence, total and canalicular efflux were likely slightly
underestimated in HepaRG cells.
Noteworthy, when canalicular efflux was estimated from
measurement of radioactivity in either cell lysates (method II)
or buffers (method III) the difference between HepaRG cells and
SCHHs did not exceed 9.3% and comparable values were found
in HepaRG cells and CCHHs. These limited differences between
the three cell models compared with the differences in BEI
values could probably be explained by the fact that the values
obtained from cell lysates and buffers are based on total TCA
efflux and not on TCA intracellular and bile canaliculi content
(Liu et al., 1999).
The contribution of passive membrane permeability was
also estimated by measuring radioactivity in either cell lysates
or buffers after a 30-min incubation at 4C (Jemnitz et al., 2010).
High values of passive permeability reaching nearly 40%
were obtained with CCHHs (in both lysates and buffers) and
with HepaRG cells (cell lysates), whereas these values were
much lower in SCHHs (in both lysates and buffers representing
19.1 and 23.4%, respectively) and in HepaRG cells (in buffers rep-
resenting 19.1%). Moreover, large interassay variations were
apparent in the two HH models. Noticeably, around 30% diffu-
sion was also reported with rat hepatocytes which have a
higher basolateral efflux activity than HHs (Jemnitz et al., 2010).
All these data lead to the conclusion that the experimental
conditions used to evaluate passive permeability may result
in its overestimation. This could at least partly be due to exces-
sive release of TCA, for instance during cell detachment
from the culture dishes. Obviously, analysis of passive perme-
ability in the three liver cell models deserves further
investigations.
In conclusion, this study demonstrated that HepaRG hepato-
cytes displayed a set of main hepatobiliary transporter proteins
(NTCP, MRP3, BSEP, MRP2, MDR1, and MDR3) at the appropriate
membrane domains and all the tested ones (NTCP, BSEP, and
MDRs) were functional as in primary HHs. To our best knowl-
edge, this work is the first comparative localization and func-
tional activity evaluation of the main membrane transporters in
HepaRG cells and primary HHs. Analysis of basolateral and
canalicular TCA efflux showed that the excretion mode of TCA
was comparable in both cell models. However, some quantita-
tive differences in relative canalicular and basolateral efflux
were observed; they could be explained not only by variations
in the levels of NTCP, BSEP, and basolateral efflux transporters
but also by the size of the bile canaliculi network and its con-
striction/relaxation activity. HepaRG hepatocytes have already
shown their unique interest for analyzing bile canaliculi func-
tion and response to cholestatic agents (Antherieu et al., 2013;
Bachour-El Azzi et al., 2014; Sharanek et al., 2014). The data
reported in this study bring further information on mechanisms
by which bile acids can accumulate and be excreted in either
HepaRG cells or primary hepatocytes. Altogether our data sup-
port the conclusion that with the advantages to be a reproduci-
ble and easy to handle cell model, HepaRG hepatocytes
represent a unique model for investigating hepatobiliary trans-
port and xenobiotic effects on canalicular efflux and cholesta-
sis-induced features.
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